Search
for
Sort by
Research 61–90 of 1000+
- Correction to: An evaluation of the federal adverse events reporting system data on adverse effects of 5‑alpha reductase inhibitors
- Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer
- Long-term treatment with finasteride: sexual adverse events and fracture rates
- Sexual adverse events-related to dutasteride e finasteride: analysis of real-life data from Eudra-Vigilance database
- Association of Hair Loss With Suicidality and Psychological Adverse Events vs Finasteride Use
- Drug-induced erectile dysfunction: a real-world pharmacovigilance study using the FDA adverse event reporting system database
- 0348 Adverse event reports of alopecia for sunscreen ingredients and branded products
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Hidradenitis suppurativa and major adverse cardiac events: A systematic review and meta-analysis
- 42276 Long-Term Safety of Ixekizumab Treatment in Adult Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: A Post-hoc Analysis of End-Of-Study Program Data Relating to Major Adverse Cardiovascular Events
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®)
- Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
- Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C
- Profile analysis of adverse events after boron neutron capture therapy for head and neck cancer: a sub-analysis of the JHN002 study
- Analyzing real-world adverse events of spironolactone with the FAERS database
- Supportive Oncodermatology: Addressing dermatologic adverse events associated with oncologic therapies
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Signal Detection for Adverse Events of Finasteride Using Korea Adverse Event Reporting System (KAERS) Database
- Suicidality and Psychological Adverse Events in Patients Treated with Finasteride
- Patient-reported Outcomes of Adverse Events After Perioperative Chemotherapy for Breast Cancer: A Prospective Observational Study
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database